You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bexarotene

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Bexarotene
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Cutaneous T-cell Lymphoma Trial in New York (Bexarotene, Total Skin Electron Beam (TSEB))

Recruiting
  • Cutaneous T-cell Lymphoma
  • Bexarotene
  • Total Skin Electron Beam (TSEB)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 19, 2022

Metastatic Triple-Negative Breast Carcinoma Trial in Singapore (Bexarotene, Capecitabine)

Recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Singapore, Singapore
    National Cancer Center Singapore
Jun 10, 2022

Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

Not yet recruiting
  • Mycosis Fungoides of Skin (Diagnosis)
  • +5 more
  • Med-Jet Injector
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Acute Myeloid Leukemia Trial in Philadelphia (Bexarotene)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Bexarotene
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of University of Pennsylvania
Nov 23, 2020

Primary Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma Trial in Worldwide (Brentuximab

Completed
Has Results
  • Primary Cutaneous Anaplastic Large Cell Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • +2 more
  • Los Angeles, California
  • +40 more
Dec 16, 2020

Lung Cancer Trial in Houston (Bexarotene, Erlotinib)

Completed
Has Results
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 17, 2020

Carcinoma, Non-small-cell Lung Trial in Lebanon (Bexarotene (targretin))

Terminated
Has Results
  • Carcinoma, Non-small-cell Lung
  • Bexarotene (targretin)
  • Lebanon, New Hampshire
    Norris Cotton Cancer Center
Feb 13, 2019

Lung Cancer, Nonsmall Cell Trial in Lebanon (IRX4204, erlotinib)

Suspended
  • Lung Cancer, Nonsmall Cell
  • Lebanon, New Hampshire
    Geisel School of Medicine at Dartmouth
Mar 29, 2022

Refractory Cutaneous T-cell Lymphoma Trial in United States (Bexarotene)

Completed
Has Results
  • Refractory Cutaneous T-cell Lymphoma
  • Bexarotene
  • Birmingham, Alabama
  • +16 more
Nov 8, 2019

Carcinoma, Non-small-cell Lung Trial in Lebanon, New York (erlotinib and bexarotene)

Completed
Has Results
  • Carcinoma, Non-small-cell Lung
  • erlotinib and bexarotene
  • Lebanon, New Hampshire
  • +1 more
Dec 14, 2018

Carcinoma, Non-small-cell Lung Trial in Lebanon (erlotinib (Tarceva) and bexarotene (Targretin))

Completed
Has Results
  • Carcinoma, Non-small-cell Lung
  • erlotinib (Tarceva) and bexarotene (Targretin)
  • Lebanon, New Hampshire
    Norris Cotton Cancer Center
Dec 14, 2018

Leukemia, MDS, Myelodysplastic/Myeloproliferative Diseases Trial in Baltimore (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Leukemia
  • +2 more
  • sargramostim
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 7, 2018

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Alzheimer's Disease Trial in Valencia (Genistein, Placebo)

Completed
  • Alzheimer's Disease
  • Genistein
  • Placebo
  • Valencia, Spain
  • +1 more
Sep 9, 2021

Lymphoma Trial in United States (Targretin® (bexarotene), pegylated liposomal doxorubicin HCl)

Completed
Has Results
  • Lymphoma
  • Targretin® (bexarotene)
  • pegylated liposomal doxorubicin hydrochloride
  • Hackensack, New Jersey
  • +4 more
Jul 19, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Lymphoma Trial in Worldwide (bexarotene, methoxypsoralen, UV light therapy)

Terminated
  • Lymphoma
  • bexarotene
  • +2 more
  • Graz, Austria
  • +27 more
Jul 6, 2018

Alopecia Areata Trial in Alexandria (Fractional Carbon Dioxide Laser, Microneedling using dermapen, Triamcinolone Acetonide)

Completed
  • Alopecia Areata
  • Fractional Carbon Dioxide Laser
  • +3 more
  • Alexandria, Egypt
    Faculty of Medicine, Alexandria University
Dec 6, 2020

Solid Tumors, Lymphoma, Multiple Myeloma Trial in Washington (CS-7017 and Bexarotene)

Terminated
  • Solid Tumors
  • +2 more
  • CS-7017 and Bexarotene
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 13, 2017

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in United States (Methoxsalen+ECP)

Completed
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • Chicago, Illinois
  • +6 more
Aug 15, 2018

AML, Acute Myeloid Leukemia Trial in Philadelphia (Bexarotene)

Completed
  • AML
  • Acute Myeloid Leukemia
  • Bexarotene
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of University of Pennsylvania
Jun 7, 2016

Alzheimer's Disease Trial in Las Vegas (Bexarotene, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Bexarotene
  • Placebo
  • Las Vegas, Nevada
    Cleveland Clinic Lou Ruvo Center for Brain Health
Feb 10, 2016

Alzheimer's Disease Trial in Orlando (Bexarotene, Placebo)

Completed
  • Alzheimer's Disease
  • Bexarotene
  • Placebo
  • Orlando, Florida
    Compass Research
Aug 11, 2015